These are the stocks posting the largest moves before the bell.Market Insiderread more
The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
Corporate executives and money managers have grown increasingly pessimistic about the economy as growth around the world slows.Trader Talk with Bob Pisaniread more
Facebook unveils the Portal TV, a streaming device that comes with a camera and microphones for making video calls via television.Technologyread more
U.S. homebuilding surged to more than a 12-year high in August as both single- and multi-family housing construction increased.Economyread more
Four Wall Street firms downgraded FedEx after the company's poor earnings report.Marketsread more
FedEx says trade around the world is starting to feel the squeeze of increased tariffs.Marketsread more
U.S. stock futures point to a modestly lower Wednesday morning open on Wall Street ahead of what the markets in the afternoon expect to be the Fed's second interest rate cut...Marketsread more
Mortgage applications to purchase a home increased 6% for the week and were a strong 15% higher annually.Real Estateread more
The House subcommittee that oversees consumer product investigations launched its a probe of Juul in June, holding two days of hearings in July. In a letter to Juul sent...Health and Scienceread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
Amazon.com — The online retail giant missed estimates by 26 cents at 52 cents per share. Revenue came in above estimates, but Amazon spent a considerable amount on its warehouses and delivery operations. Amazon's fast-growing web services business did see its revenue top forecasts.
Alphabet — Alphabet reported adjusted quarterly profit of $9.06 per share, above the consensus estimate of $8.63 a share. The Google parent's revenue also came in above Street forecasts, as did the number of ad clicks. Growth was fueled by increasing use of the company's services on mobile phones. Alphabet also announced a new $7 billion stock buyback program.
Baker Hughes — The shares are on watch after reports of talks with General Electric. The Wall Street Journal reported that GE was in talks to buy the oilfield services company, prompting GE to respond that it is in talks with Baker Hughes on potential partnerships but that none of the options on the table include an outright purchase.
Expedia — Expedia missed estimates by six cents a share, with adjusted quarterly profit of $2.41 per share. Revenue was essentially in line with forecasts. Shrinking hotel business margins proved to be a source of bottom line pressure during the quarter, the online travel services company said.
Stryker — Stryker saw earnings and revenue come in above analysts' estimates, with the medical device maker also raising its full-year forecast. Stryker is seeing particular strength in its medical and surgical businesses.
McKesson — McKesson reported adjusted quarterly profit of $2.94 per share, below the consensus estimate of $3.05 per share. The health care services company's revenue missed forecasts, as well, and it cut its outlook for the full year amid what it calls a softer pricing environment in its U.S. pharmaceutical business.
Hershey — The chocolate maker beat estimates by 11 cents a share, with quarterly profit of $1.29 per share. Revenue also beat forecasts. Hershey said it was seeing strength in its candy, mint, and gum categories, and experienced successful pre-Halloween marketing initiatives.
UBS — UBS saw profit for its latest quarter come in below estimates, but the Switzerland-based bank also increased reserves for potential U.S. penalties related to its sales of mortgage-backed securities. UBS maintained a downbeat outlook amid negative interest rates in its home country.
Novo Nordisk — Novo Nordisk cut its long-term growth forecast in half, saying it now expected growth of five percent compared to the 10 percent it forecast earlier this year. The world's largest insulin maker cites its difficulty in gaining a foothold in the U.S. market, which it said has become "significantly more challenging."
Sanofi — Sanofi put its European generic drug business up for sale. It also reported better-than-expected quarterly profit and lifted its guidance for the year. Strong growth at the drugmaker's Genzyme unit is among the factors boosting Sanofi's financial fortunes.
Ab InBev — The brewer cut its full-year guidance, with a fourth straight quarterly decline in Brazilian beer sales a key factor. Brazil is the company's second largest market.
Chipotle Mexican Grill — Chipotle is building a defense team of lawyers and bankers to help it oppose the efforts of activist investor Bill Ackman, according to a Reuters report. Ackman's Pershing Square is now the second largest shareholder in the restaurant chain, but hasn't yet publicly made any demands of Chipotle management.
Amgen — Amgen beat estimates on both the top and bottom lines in its latest quarterly earnings report, with the biotech giant raising its full-year forecast, as well. Amgen's results are being helped by sales of newer medicines, even though competition from biosimilar drugs took its toll on long time Amgen offerings like cancer drug Neupogen.
Newell Brands — The consumer products maker beat estimates by five cents a share, with adjusted quarterly profit of 78 cents per share. Revenue was short of forecasts, however. Newell also raised its full-year guidance to the top half of its prior forecast, now seeing adjusted 2016 profit of $2.85 to $2.90 per share, compared to consensus estimates of $2.88 a share.
Xerox — The business services company matched estimates, with adjusted quarterly profit of 27 cents per share, though revenue missed estimates. Its current-quarter forecast is largely above current consensus, and Xerox also said it is on track to complete its separation into two publicly traded companies by the end of the year.